149 related articles for article (PubMed ID: 26591573)
1. [THE INFLUENCE OF MEXIDOL AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE ON LIPOFUSCINE CONTENT IN RAT BRAIN UNDER LOCAL PERMANENT ISCHEMIA CONDITIONS].
Mirzoyan NR; Bagdasaryan NA; Alikhanyan CB; Meliksetyan VS; Bagdasaryan MG; Kukhtarova AM
Eksp Klin Farmakol; 2015; 78(8):3-6. PubMed ID: 26591573
[TBL] [Abstract][Full Text] [Related]
2. [Morphological changes in brain tissues of rat with local permanent ischemia model under the action of 2-methyl-6-ethyl-3-hydroxypyridine hemisuccinate].
Bagdasarian NA; Khostikian NG; Alikhanian KB; Meliksetian VS; Bagdasarian MG; Stepanian AG; Kukhtarova AM; Mirzoian NR
Eksp Klin Farmakol; 2014; 77(12):10-3. PubMed ID: 25739186
[TBL] [Abstract][Full Text] [Related]
3. [ANTIARRHYTHMIC EFFECTS OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE IN COMPARISON TO MEXIDOL.].
Turilova AI; Gan'shina TS; Avdyunina NI; Pyatin BM; Mirzoyan RS
Eksp Klin Farmakol; 2016; 79(7):8-11. PubMed ID: 29782738
[TBL] [Abstract][Full Text] [Related]
4. [Influence of 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate on cerebral blood perfusion in rats under experimental pathology conditions].
Gan'shina TS; Gorbunov AA; Gnezdilova AV; Kurdiumov IN; Avdiunina NI; Piatin BM; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):17-22. PubMed ID: 22232909
[TBL] [Abstract][Full Text] [Related]
5. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
[TBL] [Abstract][Full Text] [Related]
6. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].
Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Gatsura VV; Smirnov LD
Eksp Klin Farmakol; 1999; 62(5):15-7. PubMed ID: 10572744
[TBL] [Abstract][Full Text] [Related]
7. [VESTIBULAR AND THERMOPROTECTIVE PROPERTIES OF A NEW ACTOPROTECTOR].
Yasnetsov VV; Tsublova EG; Yasnetsov VV; Skachilova SY; Karsanova SK; Chelnaya NA
Aviakosm Ekolog Med; 2015; 49(6):29-32. PubMed ID: 26934787
[TBL] [Abstract][Full Text] [Related]
8. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
[TBL] [Abstract][Full Text] [Related]
9. [Mexidol effect on the factor induced by hypoxia HIF-1α expression in the rat cerebral cortex in ischemia].
Yakusheva EN; Mylnikov PY; Chernykh IV; Shchulkin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):87-91. PubMed ID: 29171495
[TBL] [Abstract][Full Text] [Related]
10. [Bioenergetic mechanisms of the antihypoxic action of mexidol, the succinate-containing derivative of 3-hydroxypyridine].
Luk'ianova LD; Atabaeva RE; Shepeleva SIu
Biull Eksp Biol Med; 1993 Mar; 115(3):259-60. PubMed ID: 8054612
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
Povarnina PY; Volkova AA; Gudasheva TA; Seredenin SB
Bull Exp Biol Med; 2017 Dec; 164(2):173-176. PubMed ID: 29181667
[TBL] [Abstract][Full Text] [Related]
12. [Protective effect of 3-hydroxypyridine derivatives in extreme conditions].
Iasnetsov VV
Aviakosm Ekolog Med; 2007; 41(6):5-12. PubMed ID: 18350829
[TBL] [Abstract][Full Text] [Related]
13. [STUDYING SOME PHARMACOLOGICAL EFFECTS OF NEW 3-HYDROXYPYRIDINE DERIVATIVE].
Yasnetsov VV; Tsublova EG; Yasnetsov VV; Skachilova SY; Karsanova SK; Ivanov YV
Eksp Klin Farmakol; 2016; 79(2):3-8. PubMed ID: 27416675
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxypyridine derivatives mexidol and emoxypin on the reparative processes in rabbit eye on the models of corneal epithelial defect and conjunctival ischemia.
Chesnokova NB; Beznos OV; Pavlenko TA; Zabozlaev AA; Pavlova MV
Bull Exp Biol Med; 2015 Jan; 158(3):346-8. PubMed ID: 25573366
[TBL] [Abstract][Full Text] [Related]
15. [The effect of mexidol on the dynamics of the normalization of the neurochemical and behavioral parameters of rats after deprivation of the paradoxical sleep phase].
Taranova NP; Sokolova NE; Kudriavtseva IN; Voronina TA; Nerobkova LN
Izv Akad Nauk Ser Biol; 1992; (3):479-85. PubMed ID: 1304856
[TBL] [Abstract][Full Text] [Related]
16. Antihypoxic and antinecrotic effect of mexidol in skin ischemia.
Galenko-Yaroshevskii VP; Bagmetova EN; Fil'chukova IA; Sidel'nikov AY; Popkov VA; Gorelashvili AS; Antelava NA; Sukoyan GV
Bull Exp Biol Med; 2005 Feb; 139(2):202-6. PubMed ID: 16027807
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia].
Duma SN
Ter Arkh; 2013; 85(12):100-5. PubMed ID: 24640678
[TBL] [Abstract][Full Text] [Related]
18. [A modern concept of antihypoxic and antioxidant effects of mexidol].
Shchulkin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12. Vyp. 2):87-93. PubMed ID: 30830123
[TBL] [Abstract][Full Text] [Related]
19. [Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Gorbunov AA; Gan'shina TS; Turilova AI; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):23-7. PubMed ID: 22232910
[TBL] [Abstract][Full Text] [Related]
20. [An effect of mexidol on the expression of the transcription factor Nrf2 in the rat cerebral cortex in ischemia].
Yakusheva EN; Mylnikov PY; Chernykh IV; Shchulkin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):64-68. PubMed ID: 29927406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
